Menu
04 May 2026

Corporate M&A heavyweights join Norton Rose Fulbright Dallas office

"Norton Rose Fulbright hires John Bonnet III, Mark Pendleton, Larry McFarland and Hannah Choi in Dallas to strengthen its corporate, M&A and securities practice, focusing on private equity, healthcare and energy."

John Bonnet III and Mark Pendleton have joined Norton Rose Fulbright in Dallas, and are joined by senior counsel Larry McFarland and associate Hannah Choi.

John Bonnet III joins Norton Rose Fulbright as a partner. He brings decades of experience in M&A deals, debt and equity financings, investment funds, commercial lending transactions, corporate governance, contracts, general business transactions and other business law matters. He advises companies on strategic alliances and access to capital through equity and debt offerings; his clients include startups, investment fund sponsors, strategic and passive investors, boards of directors and company management. John joins from Bradley Arant Cummings LLP, where he served as the firm’s managing partner for the Dallas office. He is licensed to practice in Texas.

Mark Pendleton joins Norton Rose Fulbright as a partner. His practice concentrates on the sales and acquisitions of companies and their assets, mergers and financing transactions, private equity platform structures and funds, corporate governance, regulatory matters, joint ventures and other corporate and commercial transactions. Focused on the private equity, healthcare and energy industries, his clients include investors, independent sponsors, management service organizations, hospitals, physician practice groups, ambulatory surgery centers, ancillary healthcare providers and startups. Mark joins from Bradley Arant Cummings LLP and is licensed to practice in Texas.

Senior counsel Larry McFarland and associate Hannah Choi join Norton Rose Fulbright in Dallas as part of the same team. Both join from Bradley Arant Cummings LLP. No further practice or prior seniority details for McFarland and Choi were provided in the announcement.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.